BHUBANESWAR: Chairman of Bharat Biotech Dr Krishna Ella called on Chief Minister Mohan Charan Majhi at Lok Seva Bhavan here ...

Pursuant to Regulation 30 and 33 of SEBI (LODR) regulations, 2015, as amended from time to time. We enclosed herewith Unaudited Standalone and Consolidated Financial results of the company for the ...

Genomic Valley Biotech, operating in the Bio Technology sector and classified as a Smallcap on the BSE, currently has its share price at ₹60.27. The stock has experienced fluctuations today ...

Bajaj Finserv Q4 Results: Cons PAT jumps 14% YoY to Rs 2,417 crore, revenue up 14%; Re 1 dividend declared Bajaj Finserv on Tuesday reported a 14% jump in its Q4FY25 net profit to Rs 2,417 crore ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Adani Green Energy Ltd (BOM:541450) achieved a record addition of 3,309 megawatts of new capacities in FY25, the highest by any renewable company in India. The company surpassed USD 1 billion in ...

The Lilly-Creyon pact will span “a broad range of diseases," the pair said in a statement, as Lilly buys into the biotech’s so-called “AI-Powered Oligo Engineering Engine.” Creyon debuted ...

E-commerce giant Meesho’s board has approved the renaming of its Indian entity from Fashnear Technologies to Meesho Pvt Ltd, according to regulatory filings accessed via Toflr. The company has ...

The antibody is in preclinical development and is expected to enter the clinic next year. The biotech hopes to bring first-in-class therapies to patients impacted by inflammation, autoimmunity and ...

From left: Eric Keller of Noveome Biotherapeutics, Heidi Wagner of ElevateBio, Krish Krishnan of Krystal Biotech, and Betty Woo of Thermo Fisher Scientific, during the Life Sciences Future PA ...

As of today, Kelun-Biotech has initiated 8 registrational clinical studies in China. MSD has initiated 12 ongoing Phase 3 global clinical studies of sac-TMT as a monotherapy or with pembrolizumab or ...